The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer.
 
Hisashi Tanaka
Speakers' Bureau - AstraZeneca Japan; Chugai Pharma; Nippon Boehringer Ingelheim; Ono Pharmaceutical
Research Funding - Lilly
 
Fumihiko Okumura
No Relationships to Disclose
 
Chiori Tabe
No Relationships to Disclose
 
Yoshiko Ishioka
No Relationships to Disclose
 
Masamichi Itoga
No Relationships to Disclose
 
Kageaki Taima
No Relationships to Disclose
 
Yukihiro Hasegawa
No Relationships to Disclose
 
Junichi Yokouchi
No Relationships to Disclose
 
Shingo Takanashi
No Relationships to Disclose
 
Masahiko Aoki
No Relationships to Disclose
 
Sadatomo Tasaka
No Relationships to Disclose